CSIMarket
 


Sierra Oncology Inc   (SRRA)
Other Ticker:  
 
 

SRRA's EPS from Cont. Operations Growth by Quarter and Year

Sierra Oncology Inc 's EPS from Cont. Operations results by quarter and year




SRRA EPS from Cont. Operations (in $) FY 2022 FY 2021 FY 2020 FY 2019
IV Quarter December - -1.66 -1.63 -0.64
III Quarter September - -2.10 -1.39 -0.17
II Quarter June - -1.67 -1.58 -0.20
I Quarter March -1.33 -1.71 -3.14 -0.17
FY   -1.33 -7.14 -7.74 -1.18



SRRA EPS from Cont. Operations first quarter 2022 Y/Y Growth Comment
Sierra Oncology Inc in the first quarter 2022 recorded EPS loss from Cont. Operations of $ -1.33 .

According to the results reported in the first quarter 2022, Sierra Oncology Inc achieved the best EPS from Cont. Operations growth in Major Pharmaceutical Preparations industry. While Sierra Oncology Inc ' s EPS from Cont. Operations no change of % ranks overall at the positon no. in the first quarter 2022.




SRRA EPS from Cont. Operations ( Y/Y Growth %) 2022
2021 2020 2019
IV Quarter December - - - -
III Quarter September - - - -
II Quarter June - - - -
I Quarter March - - - -
FY   - - - -

Financial Statements
Sierra Oncology Inc 's first quarter 2022 EPS from Cont. Operations $ -1.33 SRRA's Income Statement
Sierra Oncology Inc 's first quarter 2021 EPS from Cont. Operations $ -1.71 Quarterly SRRA's Income Statement
New: More SRRA's historic EPS from Cont. Operations Growth >>


SRRA EPS from Cont. Operations (Quarter on Quarter Growth %)

2022
2021 2020 2019
IV Quarter December - - - -
III Quarter September - - - -
II Quarter June - - - -
I Quarter March - - - -
FY (Year on Year)   - - - -




EPS from Cont. Operations first quarter 2022 Y/Y Growth Company Ranking
Within: No.
Major Pharmaceutical Preparations Industry #
Healthcare Sector #
Overall #

EPS from Cont. Operations Y/Y Growth Statistics
High Average Low
0 % 0 % 0 %
 
EPS from Cont. Operations first quarter 2022 Y/Y Growth Company Ranking
Within: No.
Major Pharmaceutical Preparations Industry #
Healthcare Sector #
Overall #
EPS from Cont. Operations Y/Y Growth Statistics
High Average Low
0 % 0 % 0 %
 

EPS from Cont. Operations by Quarter for the Fiscal Years 2019, 2020, 2021, 2022

Sierra Oncology Inc 's Q/Q EPS from Cont. Operations Growth


EPS from Cont. Operations Q/Q Growth Statistics
High Average Low
0 % 0 % 0 %
 


SRRA's I. Quarter Q/Q EPS from Cont. Operations Comment
Despite the fact, that Sierra Oncology Inc in the I. Quarter 2022 revealed EPS loss from Cont. Operations of $ -1.33 , it should be mentioned, that current results are slight up side relative to the -1.66 in the fourth quarter.

Within Major Pharmaceutical Preparations industry Sierra Oncology Inc achieved highest sequential EPS from Cont. Operations growth. While Sierra Oncology Inc 's EPS from Cont. Operations growth quarter on quarter, overall rank is .


EPS from Cont. Operations Q/Q Growth Company Ranking
Within: No.
Major Pharmaceutical Preparations Industry #
Healthcare Sector #
Overall #
EPS from Cont. Operations Q/Q Growth Company Ranking
Within: No.
Major Pharmaceutical Preparations Industry #
Healthcare Sector #
Overall #
EPS from Cont. Operations Q/Q Growth Statistics
High Average Low
0 % 0 % 0 %
 


SRRA's I. Quarter Q/Q EPS from Cont. Operations Comment
Although Sierra Oncology Inc in the I. Quarter 2022 showed EPS loss from Cont. Operations of $ -1.33 , it should be said, that current results point to recovery in contrast to the -1.66 in the fourth quarter.

Within Major Pharmaceutical Preparations industry Sierra Oncology Inc achieved highest sequential EPS from Cont. Operations growth. While Sierra Oncology Inc 's EPS from Cont. Operations growth quarter on quarter, overall rank is .


Sierra Oncology Inc 's 12 Months EPS from Cont. Operations Growth Year on Year


EPS from Cont. Operations TTM Growth

12 Months Ending
(Mar 31 2022)
12 Months Ending
(Dec 31 2021)
12 Months Ending
(Sep 30 2021)
12 Months Ending
(Jun 30 2021)
12 Months Ending
(Mar 31 2021)
Cumulative EPS from Cont. Operations 12 Months Ending $ -6.76 $ -7.14 $ -7.11 $ -6.40 $ -6.31
Y / Y EPS from Cont. Operations Growth (TTM) - - - - -
Year on Year EPS from Cont. Operations Growth Overall Ranking # # # # #
Seqeuential EPS from Cont. Operations Change (TTM) - - - - -
Seq. EPS from Cont. Operations Growth (TTM) Overall Ranking # # # # #




Cumulative EPS from Cont. Operations growth Comment
Sierra Oncology Inc ' has realized cumulative trailing twelve months EPS loss from Cont. Operations of $ -7 in the Mar 31 2022 period.

Sierra Oncology Inc achieved highest trailing twelve month year on year EPS from Cont. Operations growth. While overall EPS from Cont. Operations growth ranking, remained unchanged compare to the previous quarter at no. .

EPS from Cont. Operations TTM Q/Q Growth Statistics
High Average Low
0 %
0 %
0 %
 

EPS from Cont. Operations TTM Y/Y Growth Company Ranking
Within: No.
Major Pharmaceutical Preparations Industry #
Healthcare Sector #
Overall #

EPS from Cont. Operations TTM Y/Y Growth Statistics
High Average Low
0 %
0 %
0 %
 


EPS from Cont. Operations TTM Q/Q Growth Company Ranking
Within: No.
Industry #
Sector #
S&P 500 #
Cumulative EPS from Cont. Operations growth Comment
Sierra Oncology Inc ' has realized cumulative trailing twelve months EPS loss from Cont. Operations of $ -7 in the Mar 31 2022 period.

Sierra Oncology Inc achieved highest trailing twelve month year on year EPS from Cont. Operations growth. While overall EPS from Cont. Operations growth ranking, remained unchanged compare to the previous quarter at no. .

EPS from Cont. Operations TTM Q/Q Growth Statistics
High Average Low
0 %
0 %
0 %
 


EPS from Cont. Operations TTM Y/Y Growth Company Ranking
Within: No.
Major Pharmaceutical Preparations Industry #
Healthcare Sector #
Overall #

EPS from Cont. Operations TTM Y/Y Growth Statistics
High Average Low
0 %
0 %
0 %
 


EPS from Cont. Operations TTM Q/Q Growth Company Ranking
Within: No.
Industry #
Sector #
S&P 500 #




Other EPS from Cont. Operations Growth
Major Pharmaceutical Preparations Industry EPS from Cont. Operations Growth Trends and Statistics
Healthcare Sector EPS from Cont. Operations Growth Statistics
EPS from Cont. Operations Growth Trends for overall market
SRRA's EPS from Cont. Operations Growth Ratio versus Major Pharmaceutical Preparations Industry, Healthcare Sector and total Market
Highest Ranking EPS from Cont. Operations Growth
Lowest Ranking EPS from Cont. Operations Growth
EPS from Cont. Operations Growth for SRRA's Competitors
EPS from Cont. Operations Growth for Sierra Oncology Inc 's Suppliers
EPS from Cont. Operations Growth for SRRA's Customers

You may also want to know
SRRA's Annual Growth Rates SRRA's Profitability Ratios SRRA's Asset Turnover Ratio SRRA's Dividend Growth
SRRA's Roe SRRA's Valuation Ratios SRRA's Financial Strength Ratios SRRA's Dividend Payout Ratio
SRRA's Roa SRRA's Inventory Turnover Ratio SRRA's Growth Rates SRRA's Dividend Comparisons



Companies with similar EPS from Cont. Operations no change for the quarter ending Mar 31 2022 within Healthcare SectorY/Y Change %EPS from Cont. Operations for the quarter ending Mar 31 2022
Msa Safety Incorporated-3.23%$ -3.226 
Lemaitre Vascular Inc -3.45%$ -3.448 
Idexx Laboratories Inc-3.77%$ -3.766 
Merit Medical Systems Inc-5.00%$ -5.000 
Addus Homecare Corporation-5.26%$ -5.263 
National Research Corporation-5.56%$ -5.556 
Amgen Inc -5.61%$ -5.614 
Organon and Co -12.18%$ -12.179 
Regeneron Pharmaceuticals Inc -13.80%$ -13.800 
Natus Medical Inc-14.29%$ -14.286 
Intuitive Surgical Inc -15.24%$ -15.235 
Quest Diagnostics Inc-15.63%$ -15.625 
Universal Health Services Inc -16.67%$ -16.667 
Globus Medical Inc -17.78%$ -17.778 
Encompass Health Corporation-18.52%$ -18.519 
3m Company-18.93%$ -18.929 
Biomx Inc -22.86%$ -22.857 
Davita Inc -22.94%$ -22.936 
Biogen Inc -23.70%$ -23.704 
Hologic Inc-24.58%$ -24.583 
Lifevantage Corp-25.00%$ -25.000 
Integrated Biopharma Inc-25.00%$ -25.000 
Molecular Templates inc -25.49%$ -25.490 
Fulgent Genetics Inc -26.87%$ -26.868 
Integra Lifesciences Holdings Corp-27.78%$ -27.778 
National Healthcare Corp-28.78%$ -28.777 
Incyte Corporation-29.17%$ -29.167 
Semler Scientific Inc -31.51%$ -31.507 
Align Technology inc -32.68%$ -32.677 
Laboratory Corporation Of America Holdings-33.12%$ -33.122 




Help

About us

Advertise

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research. 
   Copyright © 2024 CSIMarket, Inc. All rights reserved. This site uses cookies to make your browsing experince better. By using this site, you agree to the Terms of Service and Privacy Policy - UPDATED (Read about our Privacy Policy)

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com